Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Mama's Creations
MAMA
$381M
| $371K | ﹤0.01% |
+122,951
| New | +$371K |
|
|
TEAD
3027
Teads Holding Co. Common Stock
TEAD
$163M
| $371K | ﹤0.01% |
75,500
-3,400
| -4% | -$16.7K |
|
3028
Dimensional US Targeted Value ETF
DFAT
$11.7B
| $371K | ﹤0.01% |
+8,000
| New | +$371K |
|
3029
Bloom Energy
BE
$15.7B
| $370K | ﹤0.01% |
22,600
-89,060
| -80% | -$1.46M |
|
3030
Offerpad Solutions
OPAD
$133M
| $370K | ﹤0.01% |
28,553
+12,146
| +74% | +$157K |
|
3031
Merus
MRUS
$5.26B
| $369K | ﹤0.01% |
+14,021
| New | +$369K |
|
3032
TScan Therapeutics
TCRX
$99.9M
| $369K | ﹤0.01% |
147,462
+135,862
| +1,171% | +$340K |
|
3033
Universal Insurance Holdings
UVE
$719M
| $369K | ﹤0.01% |
23,888
-90,712
| -79% | -$1.4M |
|
3034
iShares Gold Trust
IAU
$53.5B
| $368K | ﹤0.01% |
+10,100
| New | +$368K |
|
3035
OppFi
OPFI
$312M
| $368K | ﹤0.01% |
180,606
+57,591
| +47% | +$117K |
|
3036
Cass Information Systems
CASS
$565M
| $367K | ﹤0.01% |
+9,460
| New | +$367K |
|
3037
iShares Select U.S. REIT ETF
ICF
$1.93B
| $367K | ﹤0.01% |
+6,600
| New | +$367K |
|
3038
Dianthus Therapeutics
DNTH
$1.2B
| $365K | ﹤0.01% |
30,106
+5,518
| +22% | +$66.9K |
|
3039
5E Advanced Materials
FEAM
$85.7M
| $363K | ﹤0.01% |
4,813
+2,304
| +92% | +$174K |
|
3040
Rani Therapeutics
RANI
$23.9M
| $363K | ﹤0.01% |
88,201
+47,084
| +115% | +$194K |
|
|
CYT
3041
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
| $363K | ﹤0.01% |
139,800
-36,234
| -21% | -$94.1K |
|
3042
VanEck Pharmaceutical ETF
PPH
$627M
| $362K | ﹤0.01% |
4,600
-2,500
| -35% | -$197K |
|
3043
EuroDry
EDRY
$34M
| $361K | ﹤0.01% |
25,600
-1,100
| -4% | -$15.5K |
|
|
AUTL
3044
Autolus Therapeutics
AUTL
$367M
| $360K | ﹤0.01% |
151,200
+42,800
| +39% | +$102K |
|
3045
First Commonwealth Financial
FCF
$1.84B
| $359K | ﹤0.01% |
28,400
-87,400
| -75% | -$1.1M |
|
3046
iShares US Home Construction ETF
ITB
$3.26B
| $359K | ﹤0.01% |
4,200
-18,000
| -81% | -$1.54M |
|
3047
InvenTrust Properties
IVT
$2.33B
| $359K | ﹤0.01% |
15,500
+5,500
| +55% | +$127K |
|
3048
Actinium Pharmaceuticals
ATNM
$50.8M
| $358K | ﹤0.01% |
48,302
-53,898
| -53% | -$399K |
|
3049
Vince Holding
VNCE
$34M
| $357K | ﹤0.01% |
122,550
-3,000
| -2% | -$8.74K |
|
3050
JPMorgan BetaBuilders Japan ETF
BBJP
$14.2B
| $356K | ﹤0.01% |
+6,900
| New | +$356K |
|